vs
Side-by-side financial comparison of Goosehead Insurance, Inc. (GSHD) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Goosehead Insurance, Inc. is the larger business by last-quarter revenue ($93.1M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 23.1%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 9.2%).
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GSHD vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $75.5M |
| Net Profit | $8.0M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 16.1% | 22.7% |
| Net Margin | 8.6% | — |
| Revenue YoY | 23.1% | 27.7% |
| Net Profit YoY | 204.0% | — |
| EPS (diluted) | $0.19 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $93.1M | — | ||
| Q4 25 | $105.3M | $75.5M | ||
| Q3 25 | $90.4M | $54.5M | ||
| Q2 25 | $94.0M | $52.4M | ||
| Q1 25 | $75.6M | $46.0M | ||
| Q4 24 | $93.9M | $59.1M | ||
| Q3 24 | $78.0M | $80.5M | ||
| Q2 24 | $78.1M | $47.1M |
| Q1 26 | $8.0M | — | ||
| Q4 25 | $12.4M | — | ||
| Q3 25 | $7.9M | $8.8M | ||
| Q2 25 | $5.2M | $5.9M | ||
| Q1 25 | $2.3M | $3.0M | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $7.6M | $20.3M | ||
| Q2 24 | $6.2M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | 16.1% | — | ||
| Q4 25 | 29.4% | 22.7% | ||
| Q3 25 | 23.5% | 17.6% | ||
| Q2 25 | 16.7% | 12.7% | ||
| Q1 25 | 8.8% | 8.7% | ||
| Q4 24 | 29.7% | 22.6% | ||
| Q3 24 | 21.1% | 27.4% | ||
| Q2 24 | 19.7% | -4.6% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 11.8% | — | ||
| Q3 25 | 8.7% | 16.2% | ||
| Q2 25 | 5.5% | 11.2% | ||
| Q1 25 | 3.1% | 6.5% | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | 9.7% | 25.2% | ||
| Q2 24 | 7.9% | -9.6% |
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.48 | $0.26 | ||
| Q3 25 | $0.29 | $0.17 | ||
| Q2 25 | $0.18 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.58 | $0.40 | ||
| Q3 24 | $0.29 | $0.41 | ||
| Q2 24 | $0.24 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.7M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-121.3M | $130.3M |
| Total Assets | $392.8M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $25.7M | — | ||
| Q4 25 | $34.4M | $97.5M | ||
| Q3 25 | $51.6M | $94.4M | ||
| Q2 25 | $92.4M | $96.0M | ||
| Q1 25 | $70.2M | $93.2M | ||
| Q4 24 | $54.3M | $101.0M | ||
| Q3 24 | $47.5M | $96.7M | ||
| Q2 24 | $23.6M | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | $289.5M | $22.7M | ||
| Q3 25 | $290.0M | $34.0M | ||
| Q2 25 | $289.8M | $45.3M | ||
| Q1 25 | $290.3M | $56.7M | ||
| Q4 24 | $82.3M | $68.0M | ||
| Q3 24 | $84.6M | $79.3M | ||
| Q2 24 | $87.0M | $90.7M |
| Q1 26 | $-121.3M | — | ||
| Q4 25 | $-95.5M | $130.3M | ||
| Q3 25 | $-105.0M | $115.3M | ||
| Q2 25 | $-78.6M | $104.7M | ||
| Q1 25 | $-88.5M | $97.1M | ||
| Q4 24 | $43.9M | $92.1M | ||
| Q3 24 | $58.3M | $71.1M | ||
| Q2 24 | $39.8M | $48.5M |
| Q1 26 | $392.8M | — | ||
| Q4 25 | $414.9M | $216.3M | ||
| Q3 25 | $403.6M | $202.9M | ||
| Q2 25 | $436.6M | $194.9M | ||
| Q1 25 | $412.6M | $196.2M | ||
| Q4 24 | $397.7M | $213.3M | ||
| Q3 24 | $358.1M | $220.7M | ||
| Q2 24 | $338.2M | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 1.87× | 0.74× | ||
| Q3 24 | 1.45× | 1.12× | ||
| Q2 24 | 2.19× | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $91.8M | $14.4M | ||
| Q3 25 | $24.2M | $9.7M | ||
| Q2 25 | $28.9M | $14.1M | ||
| Q1 25 | $15.5M | $3.6M | ||
| Q4 24 | $71.5M | $15.6M | ||
| Q3 24 | $28.1M | $11.0M | ||
| Q2 24 | $18.9M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $86.1M | $14.4M | ||
| Q3 25 | $23.7M | $9.7M | ||
| Q2 25 | $27.2M | $14.1M | ||
| Q1 25 | $14.9M | $3.6M | ||
| Q4 24 | $70.6M | $15.6M | ||
| Q3 24 | $28.0M | $11.0M | ||
| Q2 24 | $18.6M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 81.8% | 19.1% | ||
| Q3 25 | 26.2% | 17.7% | ||
| Q2 25 | 28.9% | 26.8% | ||
| Q1 25 | 19.7% | 7.7% | ||
| Q4 24 | 75.1% | 26.4% | ||
| Q3 24 | 35.9% | 13.7% | ||
| Q2 24 | 23.9% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 1.8% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.38× | — | ||
| Q3 25 | 3.06× | 1.10× | ||
| Q2 25 | 5.61× | 2.41× | ||
| Q1 25 | 6.61× | 1.21× | ||
| Q4 24 | 4.82× | — | ||
| Q3 24 | 3.72× | 0.54× | ||
| Q2 24 | 3.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
PBYI
Segment breakdown not available.
